Sunday 18 October 2026
Export XFOR’s income statement to Excel — free account
X4 Pharmaceuticals, Inc.
XFOR Healthcare Biotechnology
In the quarter to June 2026, revenue grew 346.3%, EPS grew 96.3%, free cash flow grew 13.8% and total debt rose 1.21%, each against the same quarter a year earlier.
2.59
0.05
−1.89%
Follow XFOR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | — | 0.00 | — | — | — | 0.00 | 0.00 |
P/S ratio |
— | — | 0.00 | — | 0.00 | — | — | — | 26.56 | 4.82 |
Altman Z-Score |
— | — | (20.11) | — | (1.55) | — | — | — | (4.37) | (1.78) |
Altman Z″-Score (non-manufacturers) |
— | — | (45.27) | — | (3.09) | — | — | — | (9.40) | (1.48) |
P/FCF ratio |
— | — | 0.00 | — | 0.00 | — | — | — | 0.00 | 10.54 |
Beneish M-Score |
— | — | — | — | — | — | — | — | — | 8.05 |
P/Operating CF |
— | — | (0.95) | — | (7.37) | — | — | — | (4.47) | (10.90) |
P/B ratio |
— | — | 0.00 | — | 1.77 | — | — | — | 6.66 | 0.91 |
Price to Tangible BV |
— | — | 0.00 | — | 2.82 | — | — | — | 0.00 | 1.06 |
EV/Sales |
— | — | 0.00 | — | 0.00 | — | — | — | 21.90 | (0.19) |
EV/EBITDA |
— | — | 0.00 | — | 0.00 | — | — | — | 0.00 | 0.08 |
EV/Operating CF |
— | — | (0.32) | — | (1.43) | — | — | — | (0.93) | 0.08 |
EV/FCF |
— | — | (0.32) | — | (1.40) | — | — | — | (4.64) | (0.42) |
Quick Ratio |
0.36 | 7.34 | 1.39 | 13.57 | 6.66 | 5.89 | 5.50 | 5.02 | 3.16 | 9.84 |
Current Ratio |
0.47 | 7.45 | 1.18 | 13.68 | 6.97 | 6.27 | 5.76 | 5.34 | 3.41 | 10.16 |
Net Debt/EBITDA |
(0.29) | 3.02 | (0.06) | 2.04 | 0.76 | 0.64 | 1.01 | 0.56 | 0.75 | 2.06 |
Debt/Assets |
133.18% | 12.21% | 98.87% | 13.06% | 27.00% | 28.96% | 21.61% | 37.06% | 51.50% | 26.27% |
Debt/Equity |
(0.61) | 0.17 | (0.79) | 0.16 | 0.46 | 0.53 | 0.45 | 1.07 | 3.41 | 0.41 |
Asset Turnover |
0.00 | 0.00 | 0.08 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.16 |
Operating CF/Net income |
0.94 | 0.85 | 0.70 | 0.90 | 0.95 | 0.69 | 0.80 | 0.95 | 3.50 | 1.08 |
Capex/Depreciation |
(0.26) | (5.32) | (0.33) | 8.02 | (3.88) | (0.06) | (0.20) | (0.14) | 122.71 | (2.35) |
Interest Coverage |
(9.68) | (45.40) | (40.40) | (24.08) | (22.27) | (23.37) | (21.93) | (18.61) | (4.15) | (9.79) |
| 50.61% | (2,330.44%) | 395.09% | (204.85%) | (61.51%) | (149.61%) | (139.26%) | (161.67%) | (102.26%) | (75.99%) | |
| (268.79%) | (56.26%) | (79.62%) | (62.59%) | (43.82%) | (85.52%) | (70.69%) | (66.81%) | (25.50%) | (36.25%) | |
ROIC |
0.00% | 0.00% | 0.00% | (134.47%) | (137.23%) | (321.23%) | 0.00% | 0.00% | 0.00% | (566.65%) |
Return on Tangible Assets |
394.85% | (36.08%) | (2,170.17%) | (44.41%) | (85.58%) | (136.18%) | (89.72%) | (101.21%) | (46.77%) | (33.56%) |
Average Days of Receivables |
0.00 | 0.00 | 298.15 | 0.00 | 111.57 | 0.00 | 0.00 | 0.00 | 244.09 | 5.96 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 581.31% | 0.00% | 1,397.73% | 0.00% | 0.00% | 0.00% | 3,192.92% | 207.11% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 249.69% | 0.00% | 698.07% | 0.00% | 0.00% | 0.00% | 2,405.87% | 123.93% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.17 | 0.22 | 0.15 | 0.11 | 0.12 | 0.19 | 0.09 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 21.69% | 0.00% | 180.93% | 0.00% | 0.00% | 0.00% | 320.84% | 12.24% |
Graham Net Nets |
— | — | (2.04) | — | 0.26 | — | — | — | (0.08) | 0.93 |
Graham Number |
— | — | 15,711.92 | — | 0.00 | — | — | — | 0.00 | 0.00 |
Earnings Yield |
— | — | (521.47%) | — | (48.26%) | — | — | — | (25.91%) | (108.50%) |
Free Cash Flow Yield |
— | — | (398.75%) | — | (46.66%) | — | — | — | (17.77%) | 9.49% |
Revenue per Share |
0.00 | 0.00 | 228.76 | 0.00 | 4.49 | 0.00 | 0.00 | 0.00 | 0.38 | 0.83 |
Operating CF per Share |
(7,461.72) | (1,392.88) | (1,661.44) | (125.18) | (87.97) | (82.70) | (36.45) | (16.28) | (19.53) | (2.02) |
Capex per Share |
(25.17) | (24.71) | (2.22) | 2.15 | (2.04) | (0.72) | (0.05) | (0.01) | 14.57 | (0.07) |
Free Cash Flow per Share |
(7,486.90) | (1,417.58) | (1,663.66) | (123.02) | (90.01) | (83.41) | (36.50) | (16.29) | (4.96) | (2.10) |
Cash per Share |
1,046.55 | 5,019.15 | 531.63 | 328.69 | 117.72 | 95.39 | 57.54 | 19.27 | 15.23 | 5.98 |
Shareholders Equity per Share |
(5,766.90) | 3,837.06 | (811.18) | 336.60 | 108.88 | 75.12 | 35.01 | 8.62 | 3.30 | 4.40 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(5,766.90) | 3,837.06 | (811.18) | 336.60 | 108.88 | 75.12 | 35.01 | 8.62 | 3.30 | 4.40 |
Free Cash Flow |
(21.71) | (21.69) | (25.45) | (47.23) | (60.18) | (71.52) | (77.20) | (96.57) | (33.23) | (88.62) |
Working Capital |
(6.34) | 68.85 | 1.43 | 119.83 | 71.36 | 73.86 | 106.35 | 99.21 | 79.30 | 235.82 |
Capital Expenditures |
(0.07) | (0.38) | (0.03) | 0.83 | (1.36) | (0.61) | (0.10) | (0.06) | 97.67 | (3.00) |
Net Current Asset Value |
(18.61) | 56.98 | (13.02) | 97.80 | 33.24 | 35.11 | 47.14 | 25.92 | (12.12) | 157.41 |
EV/EBIT |
— | — | 0.00 | — | 0.00 | — | — | — | 0.00 | 0.08 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.45 | 0.00 | 0.00 | 0.00 | (38.20) | 0.09 |
Price to Operating Income |
— | — | 0.00 | — | 0.00 | — | — | — | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.55 | 0.17 | 0.43 | 0.26 | 0.28 | 6.77 | 0.46 | 0.56 | 1.03 | 7.02 |
Cash ROIC |
609.55% | (14.91%) | (458.22%) | (17.09%) | (32.59%) | (39.70%) | (33.66%) | (43.92%) | (16.64%) | (17.19%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 1.57 | 0.00 | 2.06 | 0.00 | 0.00 | 0.00 | 2.25 | 30.76 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.80 |
Inventory Turnover |
— | — | — | — | — | — | — | — | 0.00 | 1.58 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,948.14 | 361.13 |
Days of Inventory on Hand |
— | — | — | — | — | — | — | — | 1,290.09 | 283.97 |
Average Receivables |
1.44 | 1.48 | 2.23 | 2.43 | 1.46 | 0.83 | 0.95 | 0.86 | 1.14 | 1.14 |
Average Payables |
1.03 | 1.77 | 2.43 | 2.53 | 2.62 | 3.71 | 6.03 | 8.36 | 8.78 | 7.16 |
Average Inventory |
— | — | — | — | — | — | — | — | — | 3.65 |
Average Assets |
8.56 | 44.43 | 45.60 | 85.32 | 141.78 | 120.02 | 136.38 | 151.42 | 146.85 | 218.45 |
Average Common Equity |
(45.44) | 1.07 | (9.19) | 26.07 | 101.01 | 68.61 | 69.23 | 62.58 | 36.62 | 104.22 |
Columns are period end dates